NCT00834717View on ClinicalTrials.gov

Granisetron 1 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Healthy
Interventions
DRUG

Granisetron hydrochloride 1 mg tablets

2 x 1 mg, single dose fasting

DRUG

Kytril® 1 mg tablets

2 x 1 mg, single dose fasting

Trial Locations (1)

M1R5A3

Pharma Medica Research Inc., Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00834717 - Granisetron 1 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter